312 related articles for article (PubMed ID: 32033781)
21. The latest model has just arrived! A new experimental mouse model of PLA2R1-associated membranous nephropathy.
Beck LH
Kidney Int; 2023 Nov; 104(5):878-880. PubMed ID: 37863634
[TBL] [Abstract][Full Text] [Related]
22. APC ameliorates idiopathic membranous nephropathy by affecting podocyte apoptosis through the ERK1/2/YB-1/PLA2R1 axis.
Ke B; Shen W; Liao Y; Hu J; Tu W; Fang X
Mol Cell Biochem; 2023 Sep; 478(9):1999-2011. PubMed ID: 36588134
[TBL] [Abstract][Full Text] [Related]
23. Comprehensively characterizing cellular changes and the expression of THSD7A and PLA2R1 under multiple in vitro models of podocyte injury.
Zhang R; Shi Y; Lu Y; Wu Y; Chen M; Fan Y; Yuan L; Mao R
Cell Biochem Funct; 2022 Jul; 40(5):501-515. PubMed ID: 35670653
[TBL] [Abstract][Full Text] [Related]
24. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic role of renal biopsy in PLA
Wiech T; Stahl RAK; Hoxha E
Mod Pathol; 2019 Sep; 32(9):1320-1328. PubMed ID: 30962506
[TBL] [Abstract][Full Text] [Related]
26. Management of Membranous Nephropathy in the PLA
Bomback AS
Clin J Am Soc Nephrol; 2018 May; 13(5):784-786. PubMed ID: 29378770
[No Abstract] [Full Text] [Related]
27. [Membranous glomerulonephritis : An example of individualized medicine in nephrology].
Stahl RAK; Hoxha E
Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275
[TBL] [Abstract][Full Text] [Related]
28. Membranous nephropathy: new pathogenic mechanisms and their clinical implications.
Hoxha E; Reinhard L; Stahl RAK
Nat Rev Nephrol; 2022 Jul; 18(7):466-478. PubMed ID: 35484394
[TBL] [Abstract][Full Text] [Related]
29. Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.
Seitz-Polski B; Debiec H; Rousseau A; Dahan K; Zaghrini C; Payré C; Esnault VLM; Lambeau G; Ronco P
J Am Soc Nephrol; 2018 Feb; 29(2):401-408. PubMed ID: 29114041
[TBL] [Abstract][Full Text] [Related]
30. [Update membranous nephropathy].
Hoxha E; Huber TB
Dtsch Med Wochenschr; 2020 Oct; 145(20):1481-1485. PubMed ID: 33022730
[TBL] [Abstract][Full Text] [Related]
31. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
Seitz-Polski B; Payré C; Ambrosetti D; Albano L; Cassuto-Viguier E; Berguignat M; Jeribi A; Thouret MC; Bernard G; Benzaken S; Lambeau G; Esnault VL
Nephrol Dial Transplant; 2014 Dec; 29(12):2334-42. PubMed ID: 25063424
[TBL] [Abstract][Full Text] [Related]
32. Membranous nephropathy-one morphologic pattern with different diseases.
Hoxha E; von Haxthausen F; Wiech T; Stahl RAK
Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350
[TBL] [Abstract][Full Text] [Related]
33. Immunology of membranous nephropathy: from animal models to humans.
Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
[TBL] [Abstract][Full Text] [Related]
34. Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
Mahmud M; Pinnschmidt HO; Reinhard L; Harendza S; Wiech T; Stahl RAK; Hoxha E
PLoS One; 2019; 14(9):e0221293. PubMed ID: 31498806
[TBL] [Abstract][Full Text] [Related]
35. Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.
Seitz-Polski B; Dolla G; Payré C; Girard CA; Polidori J; Zorzi K; Birgy-Barelli E; Jullien P; Courivaud C; Krummel T; Benzaken S; Bernard G; Burtey S; Mariat C; Esnault VL; Lambeau G
J Am Soc Nephrol; 2016 May; 27(5):1517-33. PubMed ID: 26567246
[TBL] [Abstract][Full Text] [Related]
36. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.
Coenen MJ; Hofstra JM; Debiec H; Stanescu HC; Medlar AJ; Stengel B; Boland-Augé A; Groothuismink JM; Bockenhauer D; Powis SH; Mathieson PW; Brenchley PE; Kleta R; Wetzels JF; Ronco P
J Am Soc Nephrol; 2013 Mar; 24(4):677-83. PubMed ID: 23431073
[TBL] [Abstract][Full Text] [Related]
37. Genetic determinants of the development and course of membranous nephropathy.
Kamyshova ES; Bobkova IN; Gorelova IA; Каkhsurueva PA; Filatova EE
Ter Arkh; 2018 Jun; 90(6):105-111. PubMed ID: 30701913
[TBL] [Abstract][Full Text] [Related]
38. Experimental models for elderly patients with membranous nephropathy: Application and advancements.
Tang X; Dai H; Hu Y; Liu W; Zhao Q; Jiang H; Feng Z; Zhang N; Rui H; Liu B
Exp Gerontol; 2024 Jan; 185():112341. PubMed ID: 38042380
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity.
Liu W; Gao C; Liu Z; Dai H; Feng Z; Dong Z; Zheng Y; Gao Y; Tian X; Liu B
Front Immunol; 2020; 11():1846. PubMed ID: 33042109
[TBL] [Abstract][Full Text] [Related]
40. Deep analysis of total serum N-glycome suggests glyco-signatures for phospholipase A2 receptor 1-related idiopathic membranous nephropathy diagnosis.
Cai Y; Ren W; Li S; Liao R; Bian Q
J Proteomics; 2024 Jul; 303():105223. PubMed ID: 38862068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
